MMP9 and cancer: In some cancer models (e.g., leukemia and glioma), Rh1 can induce differentiation of cancer cells, reduce expression of metastasis-related factors like MMP-9, and augment immune-mediated cytotoxicity, making it an intriguing adjunct in oncology (Tam et al., 2018).